1. Home
  2. SUPN vs MGRC Comparison

SUPN vs MGRC Comparison

Compare SUPN & MGRC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Supernus Pharmaceuticals Inc.

SUPN

Supernus Pharmaceuticals Inc.

HOLD

Current Price

$45.61

Market Cap

3.0B

Sector

Health Care

ML Signal

HOLD

Logo McGrath RentCorp

MGRC

McGrath RentCorp

HOLD

Current Price

$112.90

Market Cap

2.8B

ML Signal

HOLD

Company Overview

Basic Information
Metric
SUPN
MGRC
Founded
2005
1979
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Diversified Commercial Services
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
3.0B
2.8B
IPO Year
2010
1995

Fundamental Metrics

Financial Performance
Metric
SUPN
MGRC
Price
$45.61
$112.90
Analyst Decision
Strong Buy
Buy
Analyst Count
5
2
Target Price
$61.60
$141.50
AVG Volume (30 Days)
492.7K
124.1K
Earning Date
05-05-2026
04-29-2026
Dividend Yield
N/A
1.67%
EPS Growth
N/A
N/A
EPS
N/A
1.10
Revenue
$392,755,000.00
$944,235,000.00
Revenue This Year
$22.70
$4.69
Revenue Next Year
$19.14
$4.81
P/E Ratio
N/A
$102.53
Revenue Growth
N/A
3.65
52 Week Low
$31.16
$94.99
52 Week High
$59.68
$128.41

Technical Indicators

Market Signals
Indicator
SUPN
MGRC
Relative Strength Index (RSI) 41.88 55.67
Support Level $43.67 $106.34
Resistance Level $46.89 $118.28
Average True Range (ATR) 1.46 3.00
MACD -0.17 0.14
Stochastic Oscillator 34.48 86.84

Price Performance

Historical Comparison
SUPN
MGRC

About SUPN Supernus Pharmaceuticals Inc.

Supernus Pharmaceuticals Inc is a specialty pharmaceutical company. The company is engaged in developing and commercializing products for the treatment of central nervous system diseases, including neurological and psychiatric disorders. Its diverse neuroscience portfolio includes approved treatments for epilepsy, migraine, attention-deficit hyperactivity disorder (ADHD), hypomobility in Parkinson's Disease (PD), cervical dystonia, chronic sialorrhea, dyskinesia in PD patients receiving levodopa-based therapy, and drug-induced extrapyramidal reactions in adult patients. The company's products include Trokendi XR, Oxtellar XR, Qelbree, APOKYN, XADAGO, MYOBLOC, GOCOVRI, Osmolex ER, and others.

About MGRC McGrath RentCorp

McGrath RentCorp is a diversified business-to-business rental company with three rental divisions: relocatable modular buildings, portable storage containers, and electronic test equipment. It comprises four reportable business segments, namely the Modular Building segment (Mobile Modular), which generates maximum revenue; the Portable Storage segment (Portable Storage); the Electronic Test Equipment segment (TRS-RenTelco); and its classroom manufacturing business (Enviroplex), which sells modular buildings used as classrooms in California. The company generates its revenues mainly from the rental of its equipment under operating leases, with sales of equipment occurring in the normal course of business.

Share on Social Networks: